1. Home
  2. EXPO vs TMDX Comparison

EXPO vs TMDX Comparison

Compare EXPO & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exponent Inc.

EXPO

Exponent Inc.

HOLD

Current Price

$72.03

Market Cap

3.6B

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$126.71

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXPO
TMDX
Founded
1967
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.9B
IPO Year
1990
2019

Fundamental Metrics

Financial Performance
Metric
EXPO
TMDX
Price
$72.03
$126.71
Analyst Decision
Buy
Buy
Analyst Count
2
8
Target Price
$81.00
$144.25
AVG Volume (30 Days)
470.5K
791.4K
Earning Date
02-05-2026
10-29-2025
Dividend Yield
1.66%
N/A
EPS Growth
N/A
170.70
EPS
2.03
2.54
Revenue
$531,142,000.00
$566,354,000.00
Revenue This Year
$5.35
$38.81
Revenue Next Year
$7.90
$20.49
P/E Ratio
$35.53
$50.55
Revenue Growth
4.43
41.20
52 Week Low
$63.81
$55.00
52 Week High
$97.57
$156.00

Technical Indicators

Market Signals
Indicator
EXPO
TMDX
Relative Strength Index (RSI) 47.87 47.35
Support Level $71.99 $120.82
Resistance Level $75.01 $133.29
Average True Range (ATR) 1.72 5.70
MACD -0.26 -0.88
Stochastic Oscillator 23.52 32.54

Price Performance

Historical Comparison
EXPO
TMDX

About EXPO Exponent Inc.

Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: